Prenatal diagnosis of fragile X syndrome: Results from parallel molecular and cytogenetic studies
β Scribed by Murphy, Patricia D. ;Wilmot, Patrick L. ;Shapiro, Lawrence R.
- Publisher
- John Wiley and Sons
- Year
- 1992
- Tongue
- English
- Weight
- 366 KB
- Volume
- 43
- Category
- Article
- ISSN
- 0148-7299
No coin nor oath required. For personal study only.
β¦ Synopsis
Abstract
Since 1985, we have provided coordinated DNAβbased and cytogenetic prenatal analysis for couples at risk for offspring afflicted with the fragile X [fra(X)] syndrome. To date, 40 pregnancies have been studied (22 males, 18 females). There were 5 males and 3 females identified to be at high risk by DNA but only 2 males and one female were demonstrated to be cytogenetically expressing the fra(X) prenatally. Of the other 3 males, one was a cytogenetic false negative (i.e. confirmed fra(X)+ at termination of pregnancy). The other 2 remain fra(X)β and are developing normally (undetected recombinants or nonβpenetrat male carriers). All fetuses at low risk were carried to term and are reported to be normal.
π SIMILAR VOLUMES
The results of 30 prenatal diagnoses for fragile X syndrome are reported. Amniotic fluid cells were examined in 1 case, fetal blood in 4, and chorionic villi samples in the others. Of the 5 fetuses analyzed by cytogenetic methods, 1 had showed 4% of fraXq27.3 expression sites and the pregnancy was t
Prenatal diagnosis of fragile X syndrome requires detection of the full FMR1 mutation in chorionic villus or amniotic fluid cell samples. Although analysis of genomic DNA restriction fragment pattern is a highly reliable technique for identification of the full FMR1 mutation, standard Southern blot